Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6520
    +0.0020 (+0.31%)
     

  • OIL

    82.97
    +0.16 (+0.19%)
     

  • GOLD

    2,334.60
    -3.80 (-0.16%)
     

  • Bitcoin AUD

    98,175.23
    -4,194.29 (-4.10%)
     

  • CMC Crypto 200

    1,389.81
    +7.24 (+0.52%)
     

  • AUD/EUR

    0.6082
    +0.0011 (+0.19%)
     

  • AUD/NZD

    1.0951
    +0.0009 (+0.09%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,075.55
    +35.17 (+0.44%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    17,973.56
    -115.14 (-0.64%)
     

  • Hang Seng

    17,266.81
    +65.54 (+0.38%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

New Strong Sell Stocks for June 15th

Zacks Equity Research
·1-min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Acer Therapeutics ACER is a pharmaceutical company that develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The Zacks Consensus Estimate for its current year earnings has been revised 15.6% downward over the last 60 days.

Anhui Conch Cement AHCHY is a manufacturer and seller of clinkers and cement products and also provides construction and installation services for industrial purposes, logistic and loading services, and mining and related services. The Zacks Consensus Estimate for its current year earnings has been revised almost 14.8 % downward over the last 60 days.

Aviva AVVID is the leading provider of indexed annuity and indexed life insurance products. The Zacks Consensus Estimate for its current year earnings has been revised 13.7% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research